CBD Product Market Size, Trends and Insights By Source (Hemp, Marijuana), By Distribution Channel (B2B, B2C), By Application (Pharmaceutical, Wellness), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- INSYS Therapeutics Inc.
- EPIDIOLEX
- SolMic GmbH
- ENDOCA
- Folium Biosciences
- Others
Reports Description
According to Custom Market Insights (CMI ), the Global CBD Product Market was estimated at USD 3 billion in 2021 and is expected to reach USD 6.33 billion in 2022 and is anticipated to reach around USD 33 billion by 2030, growing at a CAGR of roughly 11% between 2022 and 2030.
CMI research report offers a 360-degree view of the CBD Product market’s drivers and restraints, coupled with the impact they have on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the CBD Product market.
- Because hemp naturally contains a lot of cannabidiol (CBD), a chemical molecule found in the cannabis Sativa plant, hemp is the most common source of cannabidiol for extraction purposes. In addition to treating anxiety and seizures, it also lessens discomfort. The primary factor influencing the CBD product market is the increased demand for CBD for health and wellness purposes because of its therapeutic characteristics. A significant element that is anticipated to increase the manufacture of CBD-infused goods is the increased acceptance and use of products as a result of regulatory approvals.
- More and more skincare products that treat acne and wrinkles contain cannabidiol oil. For instance, Sephora recently added a line of CBD-infused beauty products to its retail locations. Similar to this, Ulta Beauty plans to introduce a range of products based on cannabidiol. Additionally, a number of new businesses are entering the market for cosmetics containing cannabidiol. For instance, the German market for the Aphria cannabidiol-based cosmetics line was opened in 2019. Aphria is a Canadian producer and distributor of medical and recreational cannabis.
- The COVID-19 epidemic, on the other hand, has brought about massive lockdowns throughout the world, causing daily operations to collapse and altering consumer behaviour in almost every industry. Retail establishments have closed while COVID-19 reaction efforts intensify. Due to the statewide suspension of transportation and manufacture in significant raw material-producing nations like China and India, the industry began to experience a supply deficit. Additionally, the availability of additional raw materials has been restricted as a result of supply chain disruptions in the U.S., which is impacting manufacturing and, consequently, the supply chain of CBD consumer health products.
- Cannabidiol is the cannabinoid most frequently utilized for therapeutic purposes because it has no psychoactive side effects. Cannabidiol oil is utilized in numerous medical procedures, including treating anxiety & depression, stress reduction, diabetes prevention, pain relief, cancer symptom relief, and inflammation. The global market is predicted to expand at a profitable rate throughout the forecast period as a result of the growing use of CBD-based products to cure illnesses.
Report Scope
The global CBD Product market research report offers an in-depth analysis of the global market size, which is further segmented into the regional and country-level market size, and segmentation market growth. Also, it provides the market share, sales analysis, competitive landscape, the impact of domestic and global market participants, trade regulations, value chain optimization, recent key developments, strategic market growth analysis, opportunities analysis, product launches, and technological innovations. The scope of the study includes market sizing and forecast for segmentation by source, distribution channel, application, and geography.
| Feature of the Report | Details |
| Market Size in 2021 | USD 3 Billion |
| Projected Market Size in 2030 | USD 33 Billion |
| Market Size in 2022 | USD 6.33 Billion |
| CAGR Growth Rate | 11% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Source, Distribution Channel, Application, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Key Market Dynamics
- Due to its medicinal properties, cannabidiol (CBD) is in high demand for health and wellness-related reasons, which is a key factor driving the global CBD product market expansion. Furthermore, the development of CBD-infused products is anticipated to be encouraged by improved product acceptance and use as a result of governmental approvals.
- A customer has decided to acquire cannabidiol products despite their high price because of the public’s rising awareness of CBD’s therapeutic potential. Commercial retailers are now concentrating on promoting products made from cannabis since they have a better profit margin.
- As a result of epilepsy and other pertinent diseases, seizures are thought to benefit significantly from the therapeutic effects of CBD. Clinical trials on CBD have also demonstrated its effectiveness in treating different types of epilepsy. On the basis of this breakthrough, nations are attempting to include CBD-based treatments, which will greatly increase demand.
- Additionally, cannabidiol heals haemorrhoids, lowers psychotic episodes linked to schizophrenia, and stops cramping throughout the menstrual cycle. Leading CBD firms promote it as a therapeutic component with “no side effects,” making it a viable substitute for THC (Tetrahydrocannabinol).
- THC and cannabidiol both have effects on the immune system and the central nervous system (CNS), respectively. However, cannabidiol and THC work better together when mixed in equal proportions, providing an “entourage” effect that could influence how the cannabidiol sector develops in the future.
- Due to its anti-anxiety effects, cannabidiol is increasingly being used outside of pharmaceuticals, including as a component in sodas, mocktails, restaurants, and breweries.
The Pharmaceuticals Segment Dominated the CBD Product Market in 2021
- In 2021, the pharmaceuticals sub-segment led the CBD product market with a revenue share of more than 70.0%. Over the projection period, the segment is anticipated to expand at a profitable rate.
- Demand for products is expected to rise in the next years as a result of the growing number of trials that are now being conducted to examine the effects of CBD on specific health issues.
- Furthermore, many businesses create CBD-infused items after purchasing CBD oils in bulk. A sizable consumer base uses these items as an option for pain and stress management. As a result, the majority of these products are shown to be in the market’s growth phase.
- Over the forecast period, the pharmaceuticals segment is anticipated to develop at the fastest rate. It is projected that the market will expand more quickly as a result of the rapidly evolving transition of cannabidiol from natural remedies to prescription medications. In the pharmaceutical sector, it is also projected that rising consumer demand would be driven by greater knowledge of cannabidiol’s therapeutic effects.
Competitive Landscape
Customers can purchase products that deliver cannabidiol’s advantages without getting high. As a result, they are quickly gathering momentum. The fact that businesses are concentrating on expanding their product offerings, entering new areas, and attracting new customers has also increased competitiveness in the global CBD industry. Due to the presence of numerous firms, the market is fragmented. In order to maintain their place in the industry, numerous businesses are introducing cutting-edge items and growing their presence in various regions. Additionally, businesses are forming numerous alliances to broaden their customer bases and distribution networks.
- 2021: Greenheart CBD, an Irish Company, became the first CBD producer to introduce a decentralized financial token. The token will help the business grow and give token holders access to affordable goods.
- 2021: Through pharmaceutical-grade cannabidiol branding services, Nano Hydrate has provided product marketing services that use cutting-edge technologies to promote natural treatments. It aimed to create a cooperative program that would expand the opportunities for cannabis-infused beverages while also enabling them to introduce established brands to the specialized CBD product market.
List of the prominent players in the global CBD Product market:
- INSYS Therapeutics Inc.
- EPIDIOLEX
- SolMic GmbH
- ENDOCA
- Folium Biosciences
- Cannoid LLC
- Marijuana Company of America Inc.
- Pivot Pharmaceuticals Inc.
- HoneyB Healthy
- NuLeaf Naturals LLC
- Nightfood Holdings
- Medical Marijuana Inc.
- Pharmahemp d.o.o.
- Isodiol International Inc.
- Others
The global CBD Product market is segmented as follows:
By Source
- Hemp
- Marijuana
By Distribution Channel
- B2B
- B2C
By Application
- Pharmaceutical
- Wellness
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global CBD Product Market, (2022 – 2030) (USD Billion)
- 2.2 Global CBD Product Market : snapshot
- Chapter 3. Global CBD Product Market – Industry Analysis
- 3.1 CBD Product Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing demand for cannabidiol (CBD) for medical and wellness purposes owing to its healing properties.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Source
- 3.7.2 Market attractiveness analysis By Distribution Channel
- 3.7.3 Market attractiveness analysis By Application
- Chapter 4. Global CBD Product Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global CBD Product Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global CBD Product Market – Source Analysis
- 5.1 Global CBD Product Market overview: By Source
- 5.1.1 Global CBD Product Market share, By Source, 2021 and 2030
- 5.2 Hemp
- 5.2.1 Global CBD Product Market by Hemp , 2022 – 2030 (USD Billion)
- 5.3 Marijuana
- 5.3.1 Global CBD Product Market by Marijuana, 2022 – 2030 (USD Billion)
- 5.1 Global CBD Product Market overview: By Source
- Chapter 6. Global CBD Product Market – Distribution Channel Analysis
- 6.1 Global CBD Product Market overview: By Distribution Channel
- 6.1.1 Global CBD Product Market share, By Distribution Channel, 2021 and 2030
- 6.2 B2B
- 6.2.1 Global CBD Product Market by B2B, 2022 – 2030 (USD Billion)
- 6.3 B2C
- 6.3.1 Global CBD Product Market by B2C, 2022 – 2030 (USD Billion)
- 6.1 Global CBD Product Market overview: By Distribution Channel
- Chapter 7. Global CBD Product Market – Application Analysis
- 7.1 Global CBD Product Market overview: By Application
- 7.1.1 Global CBD Product Market share, By Application, 2021 and 2030
- 7.2 Pharmaceutical
- 7.2.1 Global CBD Product Market by Pharmaceutical, 2022 – 2030 (USD Billion)
- 7.3 Wellness
- 7.3.1 Global CBD Product Market by Wellness, 2022 – 2030 (USD Billion)
- 7.1 Global CBD Product Market overview: By Application
- Chapter 8. CBD Product Market – Regional Analysis
- 8.1 Global CBD Product Market Regional Overview
- 8.2 Global CBD Product Market Share, by Region, 2021 & 2030 (USD Billion)
- 8.3. North America
- 8.3.1 North America CBD Product Market, 2022 – 2030 (USD Billion)
- 8.3.1.1 North America CBD Product Market, by Country, 2022 – 2030 (USD Billion)
- 8.3.1 North America CBD Product Market, 2022 – 2030 (USD Billion)
- 8.4 North America CBD Product Market, by Source, 2022 – 2030
- 8.4.1 North America CBD Product Market, by Source, 2022 – 2030 (USD Billion)
- 8.5 North America CBD Product Market, by Distribution Channel, 2022 – 2030
- 8.5.1 North America CBD Product Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.6 North America CBD Product Market, by Application, 2022 – 2030
- 8.6.1 North America CBD Product Market, by Application, 2022 – 2030 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe CBD Product Market, 2022 – 2030 (USD Billion)
- 8.7.1.1 Europe CBD Product Market, by Country, 2022 – 2030 (USD Billion)
- 8.7.1 Europe CBD Product Market, 2022 – 2030 (USD Billion)
- 8.8 Europe CBD Product Market, by Source, 2022 – 2030
- 8.8.1 Europe CBD Product Market, by Source, 2022 – 2030 (USD Billion)
- 8.9 Europe CBD Product Market, by Distribution Channel, 2022 – 2030
- 8.9.1 Europe CBD Product Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.10 Europe CBD Product Market, by Application, 2022 – 2030
- 8.10.1 Europe CBD Product Market, by Application, 2022 – 2030 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific CBD Product Market, 2022 – 2030 (USD Billion)
- 8.11.1.1 Asia Pacific CBD Product Market, by Country, 2022 – 2030 (USD Billion)
- 8.11.1 Asia Pacific CBD Product Market, 2022 – 2030 (USD Billion)
- 8.12 Asia Pacific CBD Product Market, by Source, 2022 – 2030
- 8.12.1 Asia Pacific CBD Product Market, by Source, 2022 – 2030 (USD Billion)
- 8.13 Asia Pacific CBD Product Market, by Distribution Channel, 2022 – 2030
- 8.13.1 Asia Pacific CBD Product Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.14 Asia Pacific CBD Product Market, by Application, 2022 – 2030
- 8.14.1 Asia Pacific CBD Product Market, by Application, 2022 – 2030 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America CBD Product Market, 2022 – 2030 (USD Billion)
- 8.15.1.1 Latin America CBD Product Market, by Country, 2022 – 2030 (USD Billion)
- 8.15.1 Latin America CBD Product Market, 2022 – 2030 (USD Billion)
- 8.16 Latin America CBD Product Market, by Source, 2022 – 2030
- 8.16.1 Latin America CBD Product Market, by Source, 2022 – 2030 (USD Billion)
- 8.17 Latin America CBD Product Market, by Distribution Channel, 2022 – 2030
- 8.17.1 Latin America CBD Product Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.18 Latin America CBD Product Market, by Application, 2022 – 2030
- 8.18.1 Latin America CBD Product Market, by Application, 2022 – 2030 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa CBD Product Market, 2022 – 2030 (USD Billion)
- 8.19.1.1 The Middle-East and Africa CBD Product Market, by Country, 2022 – 2030 (USD Billion)
- 8.19.1 The Middle-East and Africa CBD Product Market, 2022 – 2030 (USD Billion)
- 8.20 The Middle-East and Africa CBD Product Market, by Source, 2022 – 2030
- 8.20.1 The Middle-East and Africa CBD Product Market, by Source, 2022 – 2030 (USD Billion)
- 8.21 The Middle-East and Africa CBD Product Market, by Distribution Channel, 2022 – 2030
- 8.21.1 The Middle-East and Africa CBD Product Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.22 The Middle-East and Africa CBD Product Market, by Application, 2022 – 2030
- 8.22.1 The Middle-East and Africa CBD Product Market, by Application, 2022 – 2030 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 INSYS Therapeutics Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 EPIDIOLEX
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 SolMic GmbH
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 ENDOCA
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Folium Biosciences
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Cannoid LLC
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Marijuana Company of America Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Pivot Pharmaceuticals Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 HoneyB Healthy
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 NuLeaf Naturals LLC
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Nightfood Holdings
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Medical Marijuana Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Pharmahemp d.o.o.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Isodiol International Inc.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.1 INSYS Therapeutics Inc.
List Of Figures
Figures No 1 to 22
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
FAQs
The key factors driving the market is increasing demand for cannabidiol (CBD) for medical and wellness purposes owing to its healing properties.
The global CBD Product market is expanding growth with a CAGR of approximately 11% during the forecast period (2022 to 2030).
The global CBD Product market size was valued at USD 3 Billion in 2021 and it is projected to reach around USD 33 Billion by 2030.